iBio GAAP EPS of -$1.75, revenue of $0.4M beats by $0.2M
Source: SeekingAlpha
2025-09-05 07:47:21 ET
More on iBio
- iBio prices $50M public offering
- iBio drops on proposed public offering
- Seeking Alpha’s Quant Rating on iBio
- Historical earnings data for iBio
- Financial information for iBio
Read the full article on Seeking Alpha
For further details see:
iBio GAAP EPS of -$1.75, revenue of $0.4M beats by $0.2M
iBio Inc.
NASDAQ: IBIO
IBIO Trading
2.06% G/L:
$6.41 Last:
2,193,602 Volume:
$5.71 Open:
IBIO Latest News
March 09, 2026 07:00:00 am
iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss
February 10, 2026 04:05:00 pm
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
IBIO Stock Data
$75,169,576
31,646,066
2.47%
12
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
